Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

New technology meets clinical knowledge: Diagnosing Streptococcus suis meningitis in a 67-year-old man.

Katayama M, Mori T, Hasegawa S, Kanakubo Y, Shimizu A, Hayano S, Hosokawa N, Moody S.

IDCases. 2018 Apr 5;12:119-120. doi: 10.1016/j.idcr.2018.04.001. eCollection 2018.

2.

Novel one-pot facile technique for preparing nanoparticles modified with hydrophilic polymers on the surface via block polymer-assisted emulsification/evaporation process.

Kanakubo Y, Ito F, Murakami Y.

Colloids Surf B Biointerfaces. 2010 Jun 15;78(1):85-91. doi: 10.1016/j.colsurfb.2010.02.017. Epub 2010 Feb 18.

PMID:
20223642
3.

[Advanced medical pharmacy].

Kanakubo Y.

Yakushigaku Zasshi. 1996;31(1):108-13. Japanese.

PMID:
11619100
4.

Studies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes.

Ohmori S, Takeda S, Rikihisa T, Kiuchi M, Kanakubo Y, Kitada M.

Biol Pharm Bull. 1993 Jun;16(6):571-5.

PMID:
8364509
5.

Species differences of testosterone 16-hydroxylases in liver microsomes of guinea pig, rat and dog.

Ohmori S, Taniguchi T, Rikihisa T, Kanakubo Y, Kitada M.

Xenobiotica. 1993 Apr;23(4):419-26.

PMID:
8337900
6.

Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats.

Ohmori S, Ishii I, Kuriya S, Taniguchi T, Rikihisa T, Hirose S, Kanakubo Y, Kitada M.

Drug Metab Dispos. 1993 Mar-Apr;21(2):358-63.

PMID:
8097709
7.

Immunochemical characterization and toxicological significance of P-450HFLb purified from human fetal livers.

Kitada M, Kato T, Ohmori S, Kamataki T, Itahashi K, Guengerich FP, Rikihisa T, Kanakubo Y.

Biochim Biophys Acta. 1992 Oct 27;1117(3):301-5.

PMID:
1420280
8.

Formation of reductive metabolite, 2-sulfamoylacetylphenol, from zonisamide in rat liver microsomes.

Nakasa H, Komiya M, Ohmori S, Kitada M, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1992 Jul;77(1):31-41.

PMID:
1439179
9.

[Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].

Nomura F, Ohnishi K, Ohto M, Takeda Y, Rikihisa T, Kanakubo Y.

Rinsho Byori. 1991 Oct;39(10):1093-7. Japanese.

PMID:
1762184
10.

Decrease in the specific forms of cytochrome P-450 in liver microsomes of a mutant strain of rat with hyperbilirubinuria.

Ohmori S, Kuriya S, Uesugi T, Horie T, Sagami F, Mikami T, Kawaguchi A, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1991 May;72(2):243-53.

PMID:
1876754
11.

Induction and immunohistochemical localization of cytochrome P-450 PCN by non-steroidal compound, in rat liver microsomes.

Sagami F, Tsukidate K, Fukuda T, Nakanowatari J, Horie T, Igarashi T, Kitada M, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1990 Jan;67(1):79-86.

PMID:
2326550
12.

Induction of cytochrome P-450 isozymes by chromanamine derivatives in rat liver.

Tsukidate K, Sagami F, Horie T, Fukuda T, Kitada M, Kanakubo Y.

Xenobiotica. 1989 Aug;19(8):901-12.

PMID:
2815832
13.

Polyamine lowered the hepatic lipid peroxide level in rats.

Ohmori S, Misaizu T, Kitada M, Kitagawa H, Igarashi K, Hirose S, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1988 Nov;62(2):235-49.

PMID:
3251335
14.

The proteins immunochemically related to P-450 HFLa, a major form of cytochrome P-450 in human fetal livers, are present in liver microsomes from various animal species.

Kitada M, Igoshi N, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1988 Oct;62(1):31-40.

PMID:
3144721
15.

Purification and some properties of NADPH-cytochrome P-450 reductase from crab-eating monkey liver microsomes.

Ohmori S, Kitada M, Hamada A, Igarashi T, Ueno K, Kanakubo Y, Kitagawa H.

Biochem Int. 1988 Aug;17(2):249-56.

PMID:
3142477
16.

Immunochemical similarity of P-450 HFLa, a form of cytochrome P-450 in human fetal livers, to a form of rat liver cytochrome P-450 inducible by macrolide antibiotics.

Kitada M, Igoshi N, Kamataki T, Itahashi K, Imaoka S, Komori M, Funae Y, Rikihisa T, Kanakubo Y.

Arch Biochem Biophys. 1988 Jul;264(1):61-6.

PMID:
3395131
17.

P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y.

J Biol Chem. 1987 Oct 5;262(28):13534-7.

18.

6-Fluoro-2-methylspiro(chroman-4,4'-imidazolidine)-2',5'-dione and related compounds as inducers of monooxygenase in rat liver microsomes.

Horie T, Kitada M, Yoshioka H, Kanakubo Y, Omura T.

Drug Metab Dispos. 1987 Jul-Aug;15(4):560-4.

PMID:
2888631
19.

Sex difference in responsiveness to Aztreonam of monooxygenase system in liver microsomes from rats.

Horie T, Kitada M, Tanabe Y, Kanakubo Y.

Biochem Pharmacol. 1987 Apr 1;36(7):1053-7.

PMID:
3566801
20.

Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kanakubo Y.

Biochem Pharmacol. 1987 Feb 15;36(4):453-6.

PMID:
3493777
21.

Effects of cytochrome b5 on aniline hydroxylation catalyzed by a reconstituted system containing acetone or 2,2'-bipyridine.

Kitada M, Yamaguchi N, Rikihisa T, Kanakubo Y, Kitagawa H.

Jpn J Pharmacol. 1986 Feb;40(2):347-9.

22.

Enhancement of aniline hydroxylation in human liver microsomes.

Kitada M, Hasunuma Y, Rikihisa T, Kanakubo Y.

Res Commun Chem Pathol Pharmacol. 1986 Jan;51(1):101-16.

PMID:
3081974
23.

Immunochemical examinations of cytochrome P-450 in various tissues of human fetuses using antibodies to human fetal cytochrome P-450, P-450 HFLa.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y.

Biochem Biophys Res Commun. 1985 Sep 30;131(3):1154-9.

PMID:
4052083
24.

Purification and properties of cytochrome P-450 from homogenates of human fetal livers.

Kitada M, Kamataki T, Itahashi K, Rikihisa T, Kato R, Kanakubo Y.

Arch Biochem Biophys. 1985 Aug 15;241(1):275-80.

PMID:
4026319
25.

[A survey on the current status and trends in bladder irrigation].

Kobayashi S, Kanakubo Y, Iwasaki Y, Yashiro H, Iizuka S, Kato H, Suzuki H, Sanada Y, Sotoma T.

Hinyokika Kiyo. 1985 Jul;31(7):1243-52. Japanese.

26.

Separation, partial purification and characterization of cytochrome P-450 having different affinities for NADPH-cytochrome P-450 reductase from rat liver microsomes.

Ohmori S, Tsuruzoe N, Kitada M, Kitagawa H, Kanakubo Y.

Biochem Pharmacol. 1985 May 15;34(10):1846-9. No abstract available.

PMID:
3924050
27.
28.

Purification and properties of cytochrome P-450 from untreated monkey liver microsomes.

Ohmori S, Motohashi K, Kitada M, Kanakubo Y, Igarashi T, Ueno K, Kitagawa H.

Biochem Biophys Res Commun. 1984 Dec 28;125(3):1089-95.

PMID:
6517938
29.
30.

Inhibitory action of macrocyclic polyamines on lipid peroxidation in rat liver microsomes.

Kitada M, Igarashi K, Ohmori S, Kitagawa H, Hirose S, Kanakubo Y, Yatsunami T, Kimura E.

Biochem Pharmacol. 1982 Apr 15;31(8):1658-61. No abstract available.

PMID:
6807325
31.

Possible mechanism of inhibition by polyamines of lipid peroxidation in rat liver microsomes.

Kitada M, Naito Y, Igarashi K, Hirose S, Kanakubo Y, Kitagawa H.

Res Commun Chem Pathol Pharmacol. 1981 Sep;33(3):487-97.

PMID:
7330453
32.

Sex difference in N-demethylation activity of ethylmorphine in rat liver microsomes.

Kitada M, Omori S, Igarashi T, Kanakubo Y, Kitagawa H.

Biochem Biophys Res Commun. 1980 Dec 31;97(4):1527-34. No abstract available.

PMID:
6783038
33.

Supplemental Content

Loading ...
Support Center